Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Practice Operations · For practice managers

Closed System PRP Kits vs Open System Centrifuge Costs

Published November 17, 2026

Primary Cost Drivers
Consumables + Staff Labor

True cost-per-treatment calculations must combine direct kit or tube expenses with ancillary syringes, anticoagulants, and hands-on clinical preparation time.

Regulatory Distinction
510(k) In Vivo vs. In Vitro

Closed PRP systems carry FDA 510(k) clearance for point-of-care autologous preparation, whereas standard lab tubes are generally cleared only for diagnostic testing.

Preparation Workflow
Mechanical vs. Manual Isolation

Closed systems isolate cellular layers inside a sealed chamber to prevent ambient air exposure, while open systems require manual uncapping and aspiration.

In comparing closed system PRP kits versus open system centrifuge costs, open systems offer lower initial tube pricing but introduce substantial sterile-handling overhead, operator-dependent pipetting time, and inconsistent platelet concentrations. Closed-system kits maintain an isolated fluid path that eliminates clean-air bench requirements while standardizing therapeutic yields across clinical staff. Review the procedure volume thresholds and operational variables that determine the actual breakeven point for your clinic.

Understanding the Operational Difference: Closed vs. Open PRP Systems

Before modeling the financial impact on your practice, it is necessary to define what separates these two processing methods from a regulatory and workflow standpoint.

An open system typically relies on standard laboratory blood collection tubes—often vacuum-sealed glass or plastic tubes containing an anticoagulant—paired with a general-purpose benchtop centrifuge. It is designated as "open" because, during the separation and extraction process, the blood sample is exposed to the ambient air of the clinic room. Staff must manually uncap tubes, pipette or draw off specific layers (such as the buffy coat or platelet-poor plasma), and transfer the sample between multiple syringes or secondary tubes.

A closed system utilizes an integrated, commercially manufactured device—usually an FDA 510(k)-cleared kit paired with a calibrated centrifuge—designed specifically for preparing platelet-rich plasma at the point of care. From venipuncture through centrifugation and final syringe extraction, the autologous sample remains isolated from the ambient environment via sterile ports, Luer-lock valves, or self-contained chambers.

When evaluating biologics and point-of-care preparation systems, administrators often discover that the label on the box dictates both the clinical workflow and the practice's regulatory exposure.

Breaking Down the True Cost Per Treatment

A common procurement pitfall occurs when an administrator compares the unit price of a comprehensive closed PRP kit solely against the unit price of two or three standard laboratory tubes. To capture an accurate financial picture, you must calculate the fully loaded cost per procedure.

1. Direct Consumable Costs vs. Hidden Ancillaries

Open systems appear inexpensive on paper because individual vacuum tubes are low-cost commodities. However, a tube alone does not constitute a complete procedure kit. When running an open system, the practice manager must separately source, track, and pay for:

  • Butterfly needles or blood collection sets
  • Anticoagulant solutions (such as ACD-A) and the needles required to draw them
  • Multiple syringes of varying sizes for extraction and transfer
  • Long spinal or aspiration needles to reach the buffy coat layer
  • Transfer hubs, stopcocks, and sterile caps

Closed systems package these matched components into a single, lot-tracked unit. While the line-item cost of the kit is higher, it consolidates your procurement ledger and eliminates piecemeal ordering of medical supplies and disposables.

2. Staff Labor and Room Turnover

In a busy medical practice, clinical staff time is one of your highest fixed expenses. Open-system preparation is notoriously technique-dependent and labor-intensive. A medical assistant or nurse must carefully balance the centrifuge using water-filled counterbalance tubes, run a spin cycle, manually aspirate plasma layers without disturbing the red blood cell interface, transfer the fluid to a second tube, run a second spin cycle, and manually harvest the final concentration.

This process can easily occupy 20 to 30 minutes of focused staff attention per patient. If an assistant accidentally aspirates red blood cells due to a rushed transfer, the sample may be compromised, requiring a redraw or yielding a suboptimal clinical product.

Closed systems are engineered for speed and mechanical isolation. Using physical gel barriers, dual-chamber designs, or floating shelves, closed kits isolate the platelet layer automatically during centrifugation. Staff hands-on time drops to a few minutes of connecting syringes to Luer-lock ports, allowing your clinical team to turn over procedure rooms faster and manage higher patient volumes.

3. Capital Equipment and Maintenance

Both workflows require a centrifuge, but the acquisition models differ. Open systems rely on standard laboratory centrifuges where the practice is responsible for programming the exact Revolutions Per Minute (RPM) or Relative Centrifugal Force (RCF), spin duration, and braking speeds. If settings drift or are accidentally altered by staff, the output changes.

Closed system vendors frequently bundle the dedicated centrifuge with an initial consumable commitment or provide straightforward lease-to-own pathways. Furthermore, dedicated centrifuges feature pre-programmed, single-button protocols matched to the exact weight and geometry of their proprietary kits, minimizing mechanical wear and operator error.

Operational and Financial Checklist: Open vs. Closed Systems

When presenting a procurement recommendation to practice leadership, use this side-by-side operational comparison to evaluate total value:

  • Upfront Consumable Cost: Open systems have a low per-tube cost but require purchasing multiple separate ancillaries; closed systems have a higher all-in kit cost with all disposables included.
  • FDA Regulatory Status: Open laboratory tubes are commonly cleared for diagnostic blood testing (in vitro) rather than re-injection (in vivo); dedicated closed PRP systems carry specific FDA 510(k) clearance for preparing autologous platelet-rich plasma.
  • Contamination Risk: Open systems expose the biologic sample to ambient room air during uncapping and pipetting; closed systems maintain a sterile, sealed pathway from draw to syringe.
  • Staff Training & Labor: Open systems require extensive manual training and 20+ minutes of delicate harvesting per patient; closed systems utilize mechanical separation that any trained phlebotomist can execute in minutes.
  • Inventory Management: Open systems require tracking dozens of individual SKUs and expiration dates; closed systems consolidate inventory into a single, easily audited kit SKU.
  • Chart Documentation: Open systems require manual logging of multiple component lot numbers; closed kits provide unified peel-and-stick lot stickers for rapid EMR compliance.

The Clinical Perspective: Why Physicians Care About System Selection

While practice managers focus on margin, workflow, and liability, the treating physicians in your practice evaluate PRP systems through the lens of cellular yield and clinical reproducibility. Understanding their priorities helps align operational purchasing with clinical outcomes.

Physicians across diverse service lines—ranging from orthopedics and sports medicine to aesthetics and hair restoration—require specific cellular profiles depending on the tissue being treated. For example, an intra-articular knee injection may call for a leukocyte-poor PRP formulation with minimal red blood cell contamination to prevent post-injection flares, whereas a tendon or dermal procedure may call for a different concentration profile.

Open systems suffer from high operator-to-operator variability. If Nurse A harvests the buffy coat aggressively on Monday, and Medical Assistant B harvests conservatively on Wednesday, two patients receiving the exact same billed procedure receive vastly different biologic preparations. This inconsistency makes it difficult for physicians to standardize their clinical protocols or troubleshoot non-responders.

Closed systems engineer the guesswork out of cellular recovery. Because the mechanical geometry of the tube or chamber dictates the separation line, a closed system delivers consistent platelet capture rates and predictable leukocyte or erythrocyte exclusion regardless of which staff member runs the spin. Additionally, physicians are acutely aware of the medicolegal distinction between injecting blood processed in diagnostic-grade lab tubes versus an FDA-cleared medical device designed for human re-administration.

Compliance, Liability, and Patient Perception

From a risk management standpoint, the regulatory distinction between open and closed systems is critical. Standard vacuum blood collection tubes are cleared for diagnostic laboratory testing—meaning the blood goes into the tube to be analyzed by a machine and discarded. They are not cleared or sterilized with the intent that the contents will be injected back into a patient's joint, scalp, or dermis.

When a practice uses diagnostic tubes to prepare an injectable biologic, it assumes the liability of off-label device manipulation and increased infection risk from ambient exposure. Should an adverse event or joint infection occur, defending an open-air pipetting workflow performed in a standard exam room is challenging.

Furthermore, as cash-pay regenerative medicine matures, patients are increasingly educated. Presenting a sealed, professional, single-use kit in the exam room reinforces the value of a premium cash-pay procedure. Patients paying out-of-pocket for regenerative therapies expect clinical standards that match the price point of the treatment.

What This Means for Your Practice

If you are currently auditing your regenerative medicine service line or planning to launch PRP therapies for pain management, sports medicine, or wellness, take the following steps to optimize your procurement strategy:

  1. Audit Your True Open-System Costs: Pull your invoices for tubes, anticoagulants, needles, syringes, and transfer hubs, then add 25 minutes of loaded clinical staff wages per procedure. Compare this real figure—not just the tube price—against closed-system quotes.
  2. Review Your Device Clearances: Verify whether your current blood collection tubes carry FDA 510(k) clearance for in vivo autologous preparation, or if they are labeled strictly for in vitro diagnostic use.
  3. Standardize Across Specialties: If your clinic offers both musculoskeletal and aesthetic procedures, evaluate closed systems or complementary regenerative devices that allow customizable volume and leukocyte profiles within a single centrifuge footprint.
  4. Assess Vendor Support: Partner with a licensed medical distributor that provides staff training, predictable supply chain logistics, and transparent pricing without punitive long-term volume traps.

Evaluating the economics of point-of-care biologics requires balancing clinical quality with operational efficiency. To review closed-system PRP options, compare cost-per-treatment models for your patient volume, or audit your current regenerative supply chain, contact Dallas Regenerative Solutions to schedule a practice consultation.

Frequently asked questions

Why do open system PRP setups appear cheaper than closed system kits?
Open systems often quote only the cost of raw diagnostic blood collection tubes, leaving out the required syringes, anticoagulant, transfer needles, and aspiration hubs. When you add these ancillary disposables alongside 20 to 30 minutes of manual staff labor per treatment, the actual cost gap narrows considerably.
Are standard laboratory blood tubes FDA-cleared for PRP injections?
Most standard vacuum blood collection tubes are cleared strictly for in vitro diagnostic testing, meaning the blood is meant to be analyzed in a lab and discarded. Purpose-built closed PRP kits carry FDA 510(k) clearance specifically for the safe preparation of autologous platelet-rich plasma to be re-administered to the patient.
Do I need to buy a new centrifuge if our practice switches to a closed PRP system?
Many closed PRP systems require a specific rotor bucket size, swing-out angle, or counterweight calibration to ensure their mechanical separation barriers function properly. However, reputable distributors often bundle the matched centrifuge with initial kit orders or provide flexible equipment placement programs based on your clinic's monthly volume.
How does a closed PRP system reduce clinical staff time?
Closed systems use mechanical barriers, gel separators, or dual-chamber valves to isolate the platelet layer automatically during the spin cycle. Instead of manually uncapping tubes and carefully pipetting the buffy coat by eye, staff simply attach a syringe to a sterile port to withdraw the finished PRP in a few minutes.
Can one closed PRP system serve both orthopedic and aesthetic treatments?
Yes, many modern closed PRP platforms allow staff to adjust the final plasma volume or selectively include or exclude red blood cells and leukocytes based on the clinical protocol. This enables a multi-specialty practice to standardize on one centrifuge and kit family across joint injections, hair restoration, and microneedling.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →